Myriad Genetics (MYGN) Capital Expenditures (QoQ) (2009 - 2026)
Myriad Genetics (MYGN) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.89% |
| Dec 31, 2025 | 67.86% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | -47.17% |
| Mar 31, 2025 | 47.22% |
| Dec 31, 2024 | 2.86% |
| Sep 30, 2024 | -32.69% |
| Jun 30, 2024 | -22.39% |
| Mar 31, 2024 | -88.16% |
| Dec 31, 2023 | 258.54% |
| Sep 30, 2023 | -289.89% |
| Jun 30, 2023 | -20.00% |
| Mar 31, 2023 | -48.12% |
| Dec 31, 2022 | 448.46% |
| Sep 30, 2022 | -294.03% |
| Jun 30, 2022 | 6.35% |
| Mar 31, 2022 | 85.29% |
| Dec 31, 2021 | 13.33% |
| Sep 30, 2021 | -33.33% |
| Jun 30, 2021 | -36.62% |